Shareholding disclosure

Silchester International Investors Limited

Declared position

6.74%

Threshold

Crossed upwards

Timeline

Published

04.04.2003

Transaction

—

Voting rights breakdown

Voting rights acquired6.74%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T2014D1986

Beneficial owner

Silchester International Investors Limited

Declared address

Silchester International Investors Limited, London

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Silchester International Investors Limited

Vifor Pharma AG04.04.2003T2014D1986

Disclosure summary

Silchester International Investors Limited disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 04.04.2003, at 6.74% of voting rights. Notice category: Group of shareholders.

Disclosed position

6.74%

Voting rights acquired

Voting rights acquired6.74%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Silchester International Investors Limited disclosed a holding in Vifor Pharma AG, published on 04.04.2003.

Publication date04.04.2003

Issuing companyVifor Pharma AG

Beneficial ownerSilchester International Investors Limited

Declared addressSilchester International Investors Limited, London

CategoryGroup of shareholders

Voting rights acquired6.74%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT2014D1986

Source: SIX Exchange Regulation · Publication date: 04.04.2003

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open